medigraphic.com
ISSN 2007-6800 (Print)

2014, Number 2

Next >>

Rev Mex Traspl 2014; 3 (2)

Growth and development of a kidney transplant program in a Medical Unit of High Specialty, Instituto Mexicano del Seguro Socia

Muñoz-Rodríguez MR, Gómez-Díaz A

Language: Spanish
References: 19
Page: 39-43
PDF size: 217.19 Kb.


ABSTRACT

Organ and transplantation nowadays is a common and often the only therapeutic alternative in many cases of end stage renal disease. The kidney transplant program at the Medical Unit of High Specialty Hospital Specialty Adolfo Ruiz Cortines 14th began on November 23, 1988, performing the first kidney transplant from a living donor. The first transplant from a deceased donor was performed in 2001 and the first organ donation in the hospital was conducted in 2003. From 2010 to 2013, the program has had a remarkable growth in the realization of kidney transplants, since during this period 343 transplants have been performed, of which 315 come from a living donor and 28 from a deceased donor. Our survival rates are very similar to those reported in the world literature in national and international registries of results of renal transplantation and our kidney transplant program in addition to have a high volume patient practice is also academically very active. We have established a solid foundation of a high load renal transplantation program permitting our patient access to this form of renal replacement therapy through a program that accepts referrals from a wide geographical area hope of improving the quality of life and satisfaction of a population greatly needed.


REFERENCES

  1. http://www.cenatra.salud.gob.mx/interior/trasplante_estadisticas.html

  2. http://www.cenatra.salud.gob.mx/descargas/contenido/trasplante/reporte_anual_2011.pdf

  3. http://www.cenatra.salud.gob.mx/descargas/contenido/trasplante/reporte_anual_2012.pdf

  4. http://www.cenatra.salud.gob.mx/descargas/contenido/trasplante/estadisticas2013.pdf

  5. Roesch-Dietlen F. Historia de la medicina en Veracruz. Veracruz, México: Universidad Veracruzana; 2010. p. 529.

  6. http://www.cenatra.gob.mx/rnt

  7. Martínez-Mier G, Méndez-López MT, Budar-Fernández LF, Estrada-Oros J, Franco-Abaroa R, George-Micelli E et al. Pediatric renal transplantation with mycophenolate mofetil immunosuppression in a single center from México. Pediatr Transplant. 2007; 11 (2): 134-138.

  8. Opelz G, Döhler B, Ruhenstroth A et al. The collaborative transplant study registry. Transplant Rev (Orlando). 2013; 27 (2): 43-45.

  9. Noyola-Villalobos HF, Alberu-Gómez J, Gracida C, Morales-Buenrostro LE, Juárez-De la Cruz F, Martínez-Mier G et al. FERT results: results of the collaborative retrospective study in renal transplantation in Mexico: 2,586. Transplantation. 2010; 90 (2S): 926.

  10. Martínez-Mier G, Ávila-Pardo SF, Méndez-López MT, Budar-Fernández LF. Long-term results after conversion from calcineurin inhibitors to sirolimus in renal transplant patients. Clin Transplant. 2010; 24 (4): 467-473.

  11. Rial-Mdel C, Abbud-Filho M, Gonçalves RT, Martínez-Mier G, Montero C, Raffaele P et al. Individualizing early use of sirolimus in renal transplantation. Transplant Proc. 2010; 42 (10): 4518-4525.

  12. Martínez-Mier G, Ortiz-Enríquez JJ, Remes-Troche JM, Méndez-López MT, Budar-Fernández LF, García-García V. Prevalencia y predictores de la anemia postrasplante a un año en pacientes adultos de trasplante renal: Experiencia de un centro médico. Nefrología Mexicana. 2010; 31 (2): 45-49.

  13. Martínez-Mier G, López-Mendoza O, Méndez-López MT, Budar-Fernández LF, Ávila-Pardo SF, González-Velázquez F. Results of a renal transplant with multiple renal arteries in Veracruz, Mexico. Nefrología. 2012; 32 (6): 843-845. doi: 10.3265/Nefrologia.pre2012.Jun.11588.

  14. Martínez-Mier G, Ávila-Pardo SF, Méndez-López MT, Budar-Fernández LF, González-Velázquez F, Ortiz-Enríquez JJ et al. Efecto del índice de masa corporal sobre resultados postrasplante renal. Rev Mex Tras. 2012; 1: 8-14.

  15. Martínez-Mier G, Enríquez-De Los Santos H, Méndez-López MT, Ávila-Pardo SF, Budar-Fernández LF, González-Velázquez F. Rejection is a strong graft survival predictor in live donor pediatric renal transplantation using cyclosporine, mycophenolate mofetil, and steroids: 5-years outcomes in a single mexican center. Transplant Proc. 2013; 45 (4): 1442-1444. doi: 10.1016/j.transproceed.2013.02.044.

  16. Hernández-Navarrete LS, Hernández-Jiménez JD, Jiménez-López LA, Budar-Fernández LF, Méndez-López MT, Martínez-Mier G. Experience in kidney transplantation without blood transfusion. Kidney transplantation transfusion-free in Jehovah Witnesses, first communication in Mexico. Cir Ciruj. 2013; 81: 451-453.

  17. Martínez-Mier G, Castillo-Chiquete RA, Alvarado-Arenas RA, Budar-Fernández LF, Méndez-López MT, Ávila-Pardo SF et al. Complicaciones quirúrgicas gastrointestinales en los receptores de trasplante renal en Veracruz, México. Rev Mex Tras. 2013; 2: 93-96.

  18. Nava-Lacorte A, Martínez-Mier G, González-Velásquez F. Efecto del verapamilo sobre la función renal inmediata en el trasplante renal de donador vivo en el Hospital de Especialidades núm. 14, Centro Médico Nacional “Adolfo Ruiz Cortines” del Instituto Mexicano del Seguro Social. Rev Mex Trasp. 2013; 2: 101-106.

  19. Martínez-Mier G, Méndez-López MT, Budar-Fernández LF, Ávila-Pardo SF, González-Velázquez F. Conversión temprana de los inhibidores de la calcineurina (ICN) a sirolimus (SRL) como terapia de mantenimiento en pacientes con trasplante renal: 2 años de seguimiento prospectivo. Rev Mex Trasp. 2013; 2: 42-49.




2020     |     www.medigraphic.com